US equities |
MU $989.04 ▲+0.00% SNDK $1,487.33 ▲+0.00% SKHY $162.23 ▲+0.00% NVDA $226.32 ▲+0.00% INTC $101.35 ▲+0.00% META $742.96 ▲+0.00% UNH $378.52 ▲+0.00% AMD $594.24 ▲+0.00%
FinancialContent

Latest News about Novartis AG

Recent news which mentions Novartis AG

Trump's drug price ultimatum sets pharma firms scrambling
Tags Novartis AG Biotechnology Sanofi SA
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Gilead Sciences Inc AstraZeneca PLC Novo Nordisk A/S
From CNBC.com News
Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise
Tags Biotech and Pharmaceuticals Pharmaceuticals Trade
From CNBC.com News
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
Tags Sanofi SA Europe News Novartis AG
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Merck & Co Inc Novartis AG GSK plc
From CNBC.com News
Here are the top 15 companies for career growth in Singapore, according to LinkedIn
Tickers JOBS
Tags JPMorgan Chase & Co Make It Alphabet Inc
From CNBC.com News
Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind
Tags AI / Artificial Intelligence LILLY DRN Mobile
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Novartis AG Biotechnology AstraZeneca PLC
From CNBC.com News
Swiss pharma giant Novartis posts better-than-expected fourth-quarter sales
Tags Novartis AG Biotechnology Business News
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags LILLY DRN Biotech and Pharmaceuticals Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Amgen Inc Novartis AG Dexcom Inc
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Pfizer Inc Eli Lilly and Co Biotech and Pharmaceuticals
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Amgen Inc Politics Health & Science
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Bristol/Myers Squibb Co Biotech and Pharmaceuticals Politics
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Health & Science AstraZeneca PLC Merck & Co Inc
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Investing Bristol/Myers Squibb Co Pharmaceuticals
From CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
Tags Technology Microsoft Corp Alphabet Inc
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Health & Science Politics US: News
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Europe Economy Nestle SA Breaking News: Markets
From CNBC.com News
Top pharma CEO says preparedness for a new pandemic has not improved
Tags Drugs World Economic Forum Annual Meeting Health
From CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
Tags Medtronic PLC Investment strategy Markets
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Biotech and Pharmaceuticals Bristol/Myers Squibb Co Prescription drugs
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Business News Insulet Corp Pfizer Inc
From CNBC.com News
Protecting Cannabis Products & More: New Sustainable Child-Resistant Packaging By Dymapak
Tickers NVS TCNNF WBA
Tags Cannabis Ross Kirsh Novartis AG
From Benzinga
Stocks making the biggest moves premarket: Cal-Maine Foods, Intel, Apple & more
Tags Sunnova Energy International Inc Fluor Corp Intel Corp
From CNBC.com News
Novartis unit Sandoz set to start trading after completing spinoff
Tags Health & Science Novartis AG Health care industry
From CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
Tags Health & Science Amgen Inc US: News
From CNBC.com News
The ADHD drug market is already stretched thin. Now it's facing a back-to-school supply strain
Tags Biotechnology Teva Pharmaceutical Industries Ltd Novartis AG
From CNBC.com News
CVS pushes further into generic drugs with Sandoz partnership for new discount Humira
Tags Abbvie Inc Business News Biotechnology
From CNBC.com News
Stocks making the biggest moves midday: Morgan Stanley, Bank of America, Charles Schwab and more
Tags Bank of New York Mellon Corp Business Lockheed Martin Corp
From CNBC.com News